LESLIE PASCUAL: Open Payments
NPI 1932810942 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,197 in 74 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $982 · 2025 $2,197
Food & beverage: $2,197
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $781 |
| Amgen Inc. | 17 | $305 |
| Sumitomo Pharma America, Inc. | 7 | $181 |
| Novo Nordisk Inc | 3 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $148 |
| INTUITIVE SURGICAL, INC. | 1 | $122 |
| Lilly USA, LLC | 10 | $119 |
| Merck Sharp & Dohme LLC | 3 | $61 |
| ABBVIE INC. | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $57 |
Products named: AIRSUPRA, OTEZLA, GEMTESA, CAPLYTA, BREZTRI, Ozempic, Da Vinci Surgical System, FARXIGA.
Industry payments across AZ — which companies pay providers there.
